Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)最新文献

{"title":"Editorial Advisory Board","authors":"","doi":"10.1016/S1086-5802(15)30132-7","DOIUrl":"https://doi.org/10.1016/S1086-5802(15)30132-7","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Page S4"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1086-5802(15)30132-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136850948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rebif Offers Another Option for Treating Multiple Sclerosis","authors":"Melody Ryan PharmD, BCPS, CGP","doi":"10.1331/108658002762063772","DOIUrl":"10.1331/108658002762063772","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages 889-891"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/108658002762063772","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22155724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementing HIPAA Privacy Regulations in Pharmacy Practice","authors":"Susan K. Bishop, Susan C. Winckler JD, RPh","doi":"10.1331/108658002762063673","DOIUrl":"10.1331/108658002762063673","url":null,"abstract":"A worthy goal of HIPAA is to protect the privacy of patient health information. Final regulations for achieving this goal have been issued, and all covered entities, including all pharmacies that transmit health information electronically, must comply with these regulations by April 14, 2003. Pharmacists are strongly advised to begin educating themselves about the HIPAA privacy regulations and taking steps toward implementation as soon as possible. Because of the complexity of the privacy rule and the lingering ambiguities about how to implement the regulations, pharmacies also are encouraged to obtain expert guidance and stay up-to-date with the regulations and implementation recommendations posted by OCR.","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages 836-846"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/108658002762063673","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22155212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Individual and Structural Influences Shaping Pharmacists’ Decisions to Sell Syringes to Injection Drug Users in Atlanta, Georgia","authors":"Jennifer Taussig MPH,&nbsp;Benjamin Junge MHS,&nbsp;Scott Burris JD,&nbsp;T. Stephen Jones MD,&nbsp;Claire E. Sterk PhD","doi":"10.1331/1086-5802.42.0.S40.Taussig","DOIUrl":"10.1331/1086-5802.42.0.S40.Taussig","url":null,"abstract":"<div><h3>Objective</h3><p>To better understand the individual (e.g., attitudes and beliefs) and structural (e.g., laws and regulations) factors that influence and shape pharmacists’ decisions about selling syringes to injection drug users (IDUs).</p></div><div><h3>Design</h3><p>Qualitative research.</p></div><div><h3>Setting</h3><p>Metropolitan Atlanta.</p></div><div><h3>Participants</h3><p>20 practicing pharmacists who work in or near areas of high drug use in Atlanta, and nine pharmacists who are considered leaders in their profession in Georgia.</p></div><div><h3>Interventions</h3><p>Semistructured, in-depth interviews.</p></div><div><h3>Main Outcome Measures</h3><p>Individual and structural factors that influence pharmacists’ decisions about selling syringes to IDUs.</p></div><div><h3>Results</h3><p>Pharmacists reported that they use their professional discretion in making syringe sale decisions and that these decisions are influenced by individuals factors such as their personal attitudes and beliefs about the nature and causes of drug use, and by structural factors such as the Georgia Board of Pharmacy regulation stating that syringes cannot be sold if they will be used for an “unlawful purpose.”</p></div><div><h3>Conclusions</h3><p>IDUs’ access to sterile syringes from pharmacies in Atlanta, would likely be increased by (1) providing practicing pharmacists with professional education programs that describe the broad professional support for IDU access to sterile syringes and why blood-borne infection prevention is a legitimate medical purpose for selling syringes and (2) removing or modifying the restrictive Board of Pharmacy regulation governing syringe sales.</p></div>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S40-S45"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S40.Taussig","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists’ Attitudes and Concerns Regarding Syringe Sales to Injection Drug Users in Denver, Colorado","authors":"Beth A. Lewis MA,&nbsp;Stephen K. Koester PhD,&nbsp;Trevor W. Bush BA","doi":"10.1331/1086-5802.42.0.S46.Lewis","DOIUrl":"10.1331/1086-5802.42.0.S46.Lewis","url":null,"abstract":"<div><h3>Objective</h3><p>To identify factors influencing pharmacists’ decisions about selling syringes to injection drug users (IDUs).</p></div><div><h3>Design</h3><p>Audiotaped interviews.</p></div><div><h3>Setting</h3><p>Denver, Colorado.</p></div><div><h3>Participants</h3><p>Thirty-two pharmacists at 24 pharmacies.</p></div><div><h3>Intervention</h3><p>One-hour semistructured interviews.</p></div><div><h3>Main Outcome Measures</h3><p>Practices regarding syringe sales to IDUs and factors influencing the practices.</p></div><div><h3>Results</h3><p>Of the 32 pharmacists interviewed, 16 indicated that they sold syringes to all customers (“pro-sell”), 11 refused to sell unless shown proof of diabetic status (“no-sell”), and 5 were “undecided.” Several factors influenced the decision to sell. A perceived conflict between prevention of disease and prevention of drug abuse most clearly distinguished the three categories, with pro-sell pharmacists more likely than others to prioritize disease prevention and believe that syringe sales would not increase drug abuse. Business concerns, such as the effect of the presence of IDUs on other customers and the possibility of discarded syringes around the store, were especially prevalent among no-sell and undecided pharmacists. Seventeen pharmacists did not know about Colorado laws governing syringe sales. Four no-sell pharmacists used the laws to justify their decision not to sell, and two undecided pharmacists said they used the law when they did not want to sell syringes to IDU. All pharmacists supported syringe exchange programs.</p></div><div><h3>Conclusion</h3><p>One-half of the pharmacists sold syringes to IDUs, and several more indicated that they would do so if certain concerns were addressed. These data suggest that improved syringe disposal options, continuing education programs, and clarification of existing laws and regulations would encourage more pharmacists in Denver to sell syringes to IDUs.</p></div>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S46-S51"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S46.Lewis","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Encouraging Pharmacy Sale of Syringes to Injection Drug Users in New Mexico","authors":"Tim Wolfe,&nbsp;Vivian Amelunxen,&nbsp;Donald Torres,&nbsp;Steven Jenison MD,&nbsp;Jack Churchill FASCP","doi":"10.1331/1086-5802.42.0.S32.Wolfe","DOIUrl":"10.1331/1086-5802.42.0.S32.Wolfe","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S32-S33"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S32.Wolfe","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Injection Drug Users Report Good Access to Pharmacy Sale of Syringes","authors":"Wendy Reich PhD,&nbsp;Wilson M. Compton MD,MPE (director),&nbsp;Joseph C. Horton MSW (research associate),&nbsp;Linda B. Cottler PhD (professor of epidemiology),&nbsp;Renee M. Cunningham-Williams PhD,MPE (research assistant professor),&nbsp;Robert Booth PhD (professor),&nbsp;Merrill Singer PhD (associate director and chief of research),&nbsp;Carl Leukefeld DSW (professor),&nbsp;Joseph Fink BS Pharm,JD (vice president of research),&nbsp;Tom J. Stopka MHS (project director),&nbsp;Karen Fortuin Corsi MPH (project director),&nbsp;Michelle Staton Tindall MSW (project director)","doi":"10.1331/1086-5802.42.0.S68.Reich","DOIUrl":"10.1331/1086-5802.42.0.S68.Reich","url":null,"abstract":"<div><h3>Objective</h3><p>To examine injection drug users (IDUs) opinions and behavior regarding purchase of sterile syringes from pharmacies.</p></div><div><h3>Design</h3><p>Focus groups.</p></div><div><h3>Setting</h3><p>Urban and rural sites in Colorado, Connecticut, Kentucky, and Missouri.</p><p>Patients or Other Participants:</p><p>Eight focus groups, with 4 to 15 IDU participants per group.</p></div><div><h3>Interventions</h3><p>Transcripts of focus group discussions were evaluated for common themes by the authors and through the use of the software program NUD*IST.</p></div><div><h3>Main Outcome Measures</h3><p>Knowledge of human immunodeficiency virus (HIV), pharmacy use, barriers to access from pharmacies, high-risk and risk-reducing behavior, and rural/urban difference.</p></div><div><h3>Results</h3><p>Almost all participants knew the importance of using sterile syringes for disease prevention and reported buying syringes from pharmacies more than from any other source. Two IDUs believed pharmacists knew the syringes were being used for injecting drugs and perceived pharmacists’ sales of syringes to be an attempt to contribute to HIV prevention. Most IDUs reported that sterile syringes were relativity easy to buy from pharmacies, but most also reported barriers to access, such as having to buy in packs of 50 or 100, being made to sign a book, having to make up a story about being diabetic, or having the feeling that the pharmacists were demeaning them. While the majority of IDUs reported properly cleaning or not sharing syringes and safely disposing of them, others reported inadequate cleaning of syringes and instances of sharing syringes or of improper disposal. There were few differences in IDUs’ reported ability to buy syringes among states or between urban and rural sites, although the data suggest that IDUs could buy syringes more easily in the urban settings.</p></div><div><h3>Conclusion</h3><p>For the most part, participants understood the need for sterile syringes in order to protect themselves from HIV, hepatitis B virus, and hepatitis C virus and saw pharmacies as the best source of sterile syringes. Although these data are not generalizable, they suggest that pharmacists can and do serve as HIV-prevention service providers in their communities.</p></div>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S68-S72"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S68.Reich","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Minnesota Pharmacy Syringe Access Initiative: A Successful Statewide Program to Increase Injection Drug User Access to Sterile Syringes","authors":"Gary A. Novotny MPA (program manager),&nbsp;Niki U. Cotton-Oldenburg DrPH,&nbsp;Bill Bond,&nbsp;Bob Tracy (director, community affairs and education)","doi":"10.1331/1086-5802.42.0.S21.Novotny","DOIUrl":"10.1331/1086-5802.42.0.S21.Novotny","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S21-S22"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S21.Novotny","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Injection Drug Users and Pharmacists: A Call for Compassion, Cooperation, and Care","authors":"Harry L. Simpson","doi":"10.1331/1086-5802.42.0.S10.Simpson","DOIUrl":"10.1331/1086-5802.42.0.S10.Simpson","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S10-S12"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S10.Simpson","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22161301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community Sharps Disposal Program in Council Bluffs, Iowa","authors":"Donn Dierks (director),&nbsp;Dick Miller (pharmacist)","doi":"10.1331/1086-5802.42.0.S117.Dierks","DOIUrl":"10.1331/1086-5802.42.0.S117.Dierks","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"42 6","pages":"Pages S117-S118"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/1086-5802.42.0.S117.Dierks","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22162822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}